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Abstract 27 
Objective: Although patients with avoidant/restrictive food intake disorder (ARFID) 28 
often consult general pediatric services initially, existing literature mostly concentrated on 29 
intensive eating disorder treatment settings. This cross-sectional study sought to describe 30 
symptoms of ARFID and their associations with eating disorder psychopathology, quality of 31 
life, anthropometry, and physical comorbidities in a general pediatric sample. 32 
Methods: In N = 111 patients (8-18 years) seeking treatment for physical diseases, 33 
prevalence of ARFID-related restrictive eating behaviors was estimated by self-report and 34 
compared to population-based data (N = 799). Using self-report and medical record data, 35 
further ARFID diagnostic criteria were evaluated. Patients with versus without symptoms of 36 
ARFID based on self-report and medical records were compared in diverse clinical variables. 37 
Results: The prevalence of self-reported symptoms of ARFID was not higher in the 38 
inpatient than population-based sample. Only picky eating and shape concern were more 39 
common in the inpatient than population-based sample. Although 69% of the inpatient sample 40 
reported any restrictive eating behaviors, only 7.2% of patients showed symptoms of ARFID 41 
based on medical records in addition to self-report, particularly those with underweight, 42 
without significant effects for age, sex, and medical diagnoses. 43 
Discussion: The study revealed the importance of considering ARFID within the 44 
treatment of children and adolescents with physical diseases, especially for those with 45 
underweight. Further research is needed to replicate the findings with interview-based 46 
measures and to investigate the direction of effects in ARFID and its physical correlates. 47 
  48 
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Highlights 49 
⋅ Prevalence of ARFID-related restrictive eating behaviors was not higher in a general 50 
pediatric inpatient setting compared to a general population sample, but only in 51 
combination with objectively measured underweight. 52 
⋅ Prevalence of symptoms of ARFID based on self-report and medical records was 7.2% in 53 
a general pediatric sample, without differences between diverse medical diagnoses. 54 
 55 
Key words: food avoidance, selective eating, ARFID, comorbidity, prevalence  56 
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Introduction 57 
In the fifth edition of the Diagnostic and Statistical Manual for Mental Disorders 58 
(DSM-5; American Psychiatric Association [APA], 2013), “avoidant/restrictive food intake 59 
disorder” (ARFID) was introduced as a new diagnostic entity to replace and extend the DSM-60 
IV diagnosis of feeding disorder of infancy or early childhood (APA, 2000) and is applicable 61 
not only to children but also to adolescents and adults (Eddy et al., 2015; Zimmerman & 62 
Fisher, 2017). ARFID is characterized by food avoidance or restriction resulting in significant 63 
nutritional deficiency, substantial weight loss or failure to gain weight as expected, 64 
dependence on oral nutritional supplementation or enteral feeding, and/or marked interference 65 
with psychosocial functioning (APA, 2013). Although patients with ARFID may have similar 66 
physical symptoms as those with anorexia nervosa (AN), an eating disorder with substantial 67 
restriction of food intake as well (APA, 2013), such as thin appearance, interrupted growth 68 
and pubertal progression, the motives behind the disorders differ (Mammel & Ornstein, 69 
2017). In contrast to AN, patients with ARFID lack shape concerns, body image 70 
preoccupation, and drive for thinness (Norris, Spettigue, & Katzman, 2016; Schmidt, Vogel, 71 
Hiemisch, Kiess, & Hilbert, 2018). Instead, they often have a narrow range of accepted foods 72 
based on taste, texture, color, appearance, or odor, a fear of swallowing, choking or vomiting, 73 
and/or a lack of interest in food or disgust (Harris et al., 2019; Mammel & Ornstein, 2017; 74 
Norris et al., 2018; Reilly, Brown, Gray, Kaye, & Menzel, 2019; Zickgraf, Lane-Loney, 75 
Essayli, & Ornstein, 2019). Generally, ARFID has a higher prevalence in younger children 76 
and boys than other eating disorders and is frequently associated with concurrent physical and 77 
psychological symptoms, and lower quality of life (Fisher et al., 2014; Krom et al., 2019; 78 
Nicely, Lane-Loney, Masciulli, Hollenbeak, & Ornstein, 2014).  79 
 Because in many cases physical symptoms like low weight and slow growth become 80 
visible before disturbed eating habits attract attention, patients presenting with symptoms of 81 
ARFID or their caregiver often consult general pediatric, endocrinologic, or gastrointestinal 82 
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(GI) services initially (Cooney, Lieberman, Guimond, & Katzman, 2018; Eddy et al., 2015). 83 
Regarding physical symptomatology in ARFID, common clinical signs are failure to thrive, 84 
gastroesophageal reflux, constipation, nausea, early satiety, abdominal pain, and global 85 
developmental delay (Cooney et al., 2018; Eddy et al., 2015). Particularly for AN, ARFID and 86 
other restrictive eating disorders, specific nutritional deficiencies, such as the lack of vitamin 87 
C, B1, B6, B9, B12, D, or protein-calorie malnutrition and frequent vomiting can cause 88 
inflammation, atrophy of the GI system, and immune dysfunction, resulting in medical 89 
complications in the digestive system (Benezech, Hartmann, Morfin, Bertrand, & Domenech, 90 
2020; Bern & O'Brien, 2013; Bern, Woods, & Rodriguez, 2016; Hadley & Walsh, 2003; 91 
Johansson, Norring, Unell, & Johansson, 2012; Lelli et al., 2014; Reas, Zipfel, & Rø, 2014; 92 
Tomita et al., 2014). Thereby, restrictive eating disorders can be confused with GI diseases – 93 
suggesting that the diagnosis of ARFID is easily overlooked and the specific clinical 94 
consequences can be missed (Bern & O'Brien, 2013). This may be detrimental as eating 95 
disorders among children and adolescents are likely to co-occur with physical illnesses like 96 
type 1 diabetes mellitus (Colton et al., 2015; Jones, Lawson, Daneman, Olmsted, & Rodin, 97 
2000; Kelly, Howe, Hendler, & Lipman, 2005; Peducci et al., 2019; Young et al., 2013), 98 
diseases of the digestive system, autoimmune diseases, and seizures (Leffler, Dennis, 99 
Edwards George, & Kelly, 2007; Makhzoumi et al., 2019; Santonicola et al., 2019; Tegethoff, 100 
Belardi, Stalujanis, & Meinlschmidt, 2015; Zerwas et al., 2017). The refusal to eat may be 101 
conditioned to avoid food-induced symptoms of these diseases (Carlson, Moore, Tsai, 102 
Shulman, & Chumpitazi, 2014; Gerasimidis, McGrogan, & Edwards, 2011). 103 
 Notably, existing literature on ARFID is concentrating mostly on specialized eating 104 
disorder treatment settings (Bern et al., 2016; Nicely et al., 2014; Norris et al., 2014; Ornstein, 105 
Essayli, Nicely, Masciulli, & Lane-Loney, 2017). Evidence on ARFID from the general 106 
pediatric perspective is largely missing (Bryant-Waugh, 2013; Katzman, Norris, & Zucker, 107 
2019). With more knowledge about the prevalence and presentation of symptoms of ARFID, 108 
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ARFID may come more into focus of clinicians, especially in the presence of non-specific 109 
physical symptoms. Therefore, this study sought to approach common pediatric symptoms, 110 
such as underweight or GI discomfort, in a general pediatric setting from a psychological 111 
perspective for the purpose of specifying diagnostic options and improving treatment options. 112 
In this context, first, we investigated the prevalence of ARFID-related restrictive 113 
eating behaviors in a clinical sample of 8-18-year-old inpatient children and adolescents at a 114 
general pediatric hospital. The results of self-reported symptoms of ARFID will be compared 115 
to a population-based sample (Schmidt et al., 2018). We hypothesized that the prevalence of 116 
ARFID-related restrictive eating behaviors in the absence of weight and shape concerns, 117 
especially coupled with objective underweight, would be higher in inpatient children and 118 
adolescents at a pediatric hospital compared with the general population. Second, based on a 119 
review of inpatients’ medical records in addition to self-report, we evaluated the proportion of 120 
children and adolescents showing further ARFID criteria and whether these were associated 121 
with sociodemographic, anthropometric, and clinical characteristics including general and 122 
eating disorder psychopathology, and medical illness of the children and adolescents. We 123 
hypothesized that symptoms of ARFID would be associated with male versus female sex, 124 
would be negatively associated with child age and weight status, quality of life, and eating 125 
disorder psychopathology, but positively associated with health complaints. Regarding 126 
medical diagnosis, we hypothesized that diseases of the digestive system and neurological 127 
disorders would be more common in those with symptoms of ARFID than other diseases. 128 
Methods 129 
Procedure 130 
Children and adolescents were recruited and assessed 1-2 days after their admission at 131 
the general and neuropediatric clinic of a University Hospital where patients with a wide 132 
range of different pediatric diseases are treated. Included were all inpatient children and 133 
adolescents aged 8-18 years with adequate language skills between June 2018 and May 2019. 134 
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Informed assent and consent to participate were gathered from children and adolescents as 135 
well as their parents. The study was approved by the local Ethics Committee (Reg. No. 136 
031/14-ff).  137 
The inpatient sample included children and adolescents who were admitted via the 138 
emergency room, via referral from the pediatrician, or who were scheduled for intervention 139 
(e.g., operation, medical adjustment) of an already known disease. Therefore, children 140 
received a comprehensive medical check-up first. Possible mental disorders, including eating 141 
disorders, were only examined later during the hospital stay. To capture symptoms of ARFID 142 
and associated physical and mental sequelae internationally established questionnaires were 143 
handed out to inpatient children and adolescents across a broad range of weight and 144 
comorbidity. Information on ARFID-related restrictive eating behaviors and associated 145 
psychopathology was provided by child self-report, while sociodemographic data on child and 146 
parental age, sex, education (see below) were based on parent-report. Anthropometric data, 147 
physical complaints, medical diagnoses, and diagnostic criteria for ARFID were extracted 148 
from medical records. Out of 208 handed-out questionnaires, 130 participants (63%) filled out 149 
the survey. Due to short inpatient stay, reasons for study non-participation could not be 150 
gathered systematically. All participants with missing consent form (n = 13, 10%) and/or 151 
invalid responses (n = 6, 5%) were excluded from the analysis. 152 
Participants 153 
 Inpatient general pediatric sample. An a priori power analysis revealed that 154 
assuming to detect a difference in ARFID symptom prevalence of medium effect (Cramér’s V 155 
= .30) between the general pediatric and population-based sample with adequate statistical 156 
power (1-β = .85, α = .05, df = 1), N = 100 children and adolescents had to be included.  157 
The final sample consisted of N = 111 children and adolescents between 8 and 18 158 
years (M = 13.03 years, SD = 2.94). The majority of the sample were girls (n = 70, 63.1%) 159 
and went either to primary (n = 25, 22.5%) or high school (n = 53, 47.7%). Of those parents 160 
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providing information on maternal (n = 109) and paternal (n = 97) highest education, most 161 
had completed less than 12 years at school (n = 78, 71.6%, and n = 68, 70.1%). Parental age 162 
ranged from 29-68 years with a mothers’ mean age of 41.1 years (SD = 6.4, n = 110) and a 163 
fathers’ mean age of 45.2 years (SD = 7.1, n = 103).  164 
Objectively measured height and weight were used to determine participant’s BMI-165 
standard deviation score (BMI-SDS) based on German age- and sex-specific reference data 166 
(Kromeyer-Hauschild et al., 2001). Weight categories (underweight, normal weight, 167 
overweight) were determined using the < 10th, 10th – 90th, and > 90th BMI percentiles, 168 
respectively. The sample’s mean BMI-SDS was 0.15 (SD = 1.39, range -5.88 – 3.53) with 169 
14.4% (n = 16) of the children and adolescents having underweight, 63.1% (n = 70) having 170 
normal weight, and 22.5% (n = 25) having overweight. 171 
Medical records showed that indication for admission was due to headache in 18.0% 172 
(n = 20), medical adjustment for type 1 diabetes mellitus in 16.2% (n = 18), initial 173 
manifestation of type 1 diabetes mellitus in 15.3% (n = 17), seizures in 13.5% (n = 15), 174 
gastrointestinal problems, such as acute abdominal pain or diarrhea, in 11.7% (n = 13), 175 
infections in 4.5% (n = 5), other neurological complaints in 4.5% (n = 5), such as acute 176 
hemiparesis or reduced visual acuity, and diverse complaints, such as hypertensive crisis or 177 
leg weakness, in 16.2% (n = 18). Out of all 111 children and adolescents, 38.7% (n = 43) had 178 
neurological disorders, 33.3% (n = 37) had type 1 diabetes mellitus, 17.1% (n = 19) had 179 
gastrointestinal diseases, and 10.8% (n = 12) had other diseases as their main diagnosis. 180 
General population-based sample. The comparison sample of children and 181 
adolescents from the population consisted of N = 799 children and adolescents (n = 431 girls, 182 
53.9%) between 7 to 14 years (M = 10.50 years, SD = 2.02). Calculated from objectively 183 
measured weight and height, the mean BMI-SDS was 0.14 (SD = 1.13, range -3.23 – 3.47), 184 
with n = 67 (8.4%) children and adolescents having underweight, n = 595 (74.4%) having 185 
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normal weight and n = 137 (17.3%) having overweight. Detailed descriptions of the sample 186 
can be found in Schmidt et al. (2018). 187 
Measures 188 
Symptoms of ARFID in the inpatient and general population-based sample 189 
Eating Disorders in Youth-Questionnaire. The EDY-Q (Van Dyck & Hilbert, 2016) 190 
is a self-report instrument assessing early-onset restrictive eating disturbances in children and 191 
adolescents older than 7 years. The 14-item questionnaire contains 8 items on selective eating, 192 
emotional food avoidance, and functional dysphagia to cover the central variants of ARFID, 193 
two items on underweight problems, indicating the failure to meet adequate energy needs, and 194 
two items on weight and shape concern as exclusion criteria of ARFID. The two additional 195 
items on pica and rumination disorder were not included in this study’s analysis. All items 196 
were rated on a 7-point scale ranging from 0 = never to 6 = always.  197 
As previously described (Kurz, van Dyck, Dremmel, Munsch, & Hilbert, 2015, 2016; 198 
Schmidt et al., 2018), children and adolescents had to meet specific criteria to document the 199 
presence of symptoms of ARFID. The diagnostic coding proposed by Kurz et al. (2015, 2016) 200 
required the following EDY-Q items to be reported at least often (≥ 4): (disinterest in food OR 201 
sensory food avoidance OR fear of choking) and underweight problems, while weight and 202 
shape concern had to be reported less than sometimes (< 3). In addition, a broad symptom 203 
definition by Schmidt et al. (2018) was reported in the Supplement due to the fact that ARFID 204 
was found to be characterized by other restrictive eating behaviors as well (APA, 2013; 205 
Strand, von Hausswolff-Juhlin, & Welch, 2019). This latter definition of broad symptoms of 206 
ARFID additionally considered that general or emotional food avoidance, picky eating, 207 
avoidance to try new foods, or fear of swallowing could be reported at least often (≥ 4). Both 208 
diagnostic codings of the EDY-Q were shown to have discriminant validity in children > 7 209 
years for weight status and groups with varying levels of restrictive eating (Kurz et al., 2015; 210 
Schmidt et al., 2018) and Kurz et al. (2015) provided evidence for divergent validity and, for 211 
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items on exclusion criteria, convergent validity. Since ARFID can be associated with 212 
underweight, but does not have to be (APA, 2013), symptoms of ARFID were separately 213 
presented in conjunction with objectively measured underweight and without self-reported 214 
underweight being present, for informative purposes (see Table S1). On item level, all EDY-Q 215 
items reported at least often (≥ 4) were used to analyze the frequency of single ARFID-related 216 
restrictive eating behaviors. 217 
Symptoms of ARFID in the inpatient sample only 218 
Self-report plus medical record data. In addition to self-report on restrictive eating 219 
behaviors and weight and shape concern (EDY-Q), DSM-5 diagnostic criteria for ARFID 220 
were extracted from medical records including patients’ height, weight, and BMI-SDS at 221 
initial consultation, routinely assessed blood tests, psychosocial anamnesis, presenting 222 
complaints, and medical diagnoses, in order to evaluate whether the following DSM-5 criteria 223 
for ARFID were met: (A1-4) presence of weight loss or faltering growth, nutritional 224 
deficiency, enteral or supplemental feeding, and/or psychosocial impairment, (B) absence of 225 
culturally accepted behavior or lack of available food, (C) absence of anorexia nervosa, 226 
bulimia nervosa, and body image disturbance, (D) absence of medical or mental diagnoses 227 
that exclusively explain eating disturbances, or the eating disturbance warrants independent 228 
clinical attention (APA, 2013). Table S2 gives an overview on the operationalization of 229 
ARFID diagnostic criteria based on self-report and medical records.  230 
Based on predefined criteria (Eddy et al., 2015; Eddy & Thomas, 2019; Table S2), two 231 
coders (Hannah Schöffel, Ricarda Schmidt) separately screened electronical medical records 232 
of patients, who reported at least one ARFID-related restrictive eating behavior at least often 233 
(EDY-Q items ≥ 4). As ARFID was not used as a formal diagnosis by clinicians due to the use 234 
of the International Statistical Classification of diseases and related health problems (ICD-10, 235 
World Health Organization, 1993) that did not include any ARFID diagnosis so far, all 236 
diagnostic criteria were separately extracted. Each coder independently screened all eligible 237 
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cases. Inter-rater agreement for evaluating the presence or absence of ARFID diagnostic 238 
criteria was 0.46 ≤ κ ≤ 1.00 (89 ≤ % agreement ≤ 100) for diagnostic criteria and κ = 0.86 239 
(97% agreement) for a probable diagnosis, overall indicating moderate to excellent agreement 240 
(Landis & Koch, 1977). In case of discrepant ratings, the case was jointly reviewed and a 241 
decision was made by consensus. Since no clinical interview was conducted to deduce ARFID 242 
diagnosis, but only a review of the medical records, no definite ARFID diagnosis could be 243 
made. 244 
Eating disorder psychopathology 245 
Eating Disorder Examination-Questionnaire for Children 8. The ChEDE-Q8 246 
(Kliem et al., 2017) is an 8-item short-form of the Eating Disorder Examination-Questionnaire 247 
adapted to children (Goldschmidt, Doyle, & Wilfley, 2007) to assess children’s global eating 248 
disorder psychopathology during the past 28 days by self-report. The items covering restraint, 249 
eating concern, weight concern, and shape concern are answered on a 7-point scale ranging 250 
from 0 = feature was absent to 6 = feature was present every day or to an extreme degree 251 
with higher values indicating greater psychopathology. The global mean score was used for 252 
analysis (α = .94 for this study). The ChEDE-Q8 was found to show high correlation with the 253 
ChEDE-Q global score and to have divergent and discriminant validity in children and 254 
adolescents aged 8-18 years (Kliem et al., 2017; Schlüter, Schmidt, Kittel, Tetzlaff, & Hilbert, 255 
2016). 256 
Eating Disorder Inventory for Children. The EDI-C (Eklund, Paavonen, & 257 
Almqvist, 2005), the child version of the EDI-2 (Kappel et al., 2012), was used to measure 258 
specific aspects of eating disorder psychopathology. Out of the 11 EDI-C subscales, only the 259 
subscales drive for thinness (7 items), bulimia (7 items), and body dissatisfaction (9 items) 260 
were administered. Each item was rated on a 6-point scale ranging from 0 = never to 5 = 261 
always with higher values indicating greater psychopathology. Subscale sum scores were 262 
calculated (.85 ≤ α ≤ .92 for this study). The EDI-C was found to have convergent and 263 
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discriminant validity in children aged 10-18 years (Salbach-Andrae et al., 2010; Thiels & 264 
Pätel, 2008). 265 
Quality of life 266 
The KINDL-R (Bullinger, 1994) is a German self-report questionnaire to measure 267 
health-related quality of life in children and adolescents over the past week. In this study, the 268 
two subscales physical and emotional well-being with 4 items each were used. Responses on 269 
all items were given on a 5-point Likert scale ranging from 1 = never to 5 = always. Subscale 270 
sum scores were calculated with higher values indicating better physical (α = .80 for this 271 
study) or mental (α = .68 for this study) quality of life. The KINDL-R was found to have 272 
convergent, divergent, and discriminant validity in children 7-18 years (Ravens-Sieberer & 273 
Bullinger, 2000). 274 
Health complaints 275 
The Health Behavior in School-aged Children Symptom Checklist (HBSC-SCL; 276 
Ravens-Sieberer et al., 2008) is an 8-item self-report questionnaire to measure children’s 277 
health complaints such as headache, stomach ache, or feeling nervous over the previous 6 278 
months. All items were rated on a 5-point scale ranging from 0 = rarely or never to 4 = about 279 
every day. A total sum score was calculated (α = .69 for this study). The HBSC-SCL was 280 
found to be a unidimensional measure with convergent and divergent validity in children 8-18 281 
years (Gariepy, McKinnon, Sentenac, & Elgar, 2016; Ravens-Sieberer et al., 2008; Ravens-282 
Sieberer et al., 2010). 283 
Statistical Analysis 284 
First, the prevalence of self-reported symptoms of ARFID based on the EDY-Q was 285 
descriptively presented for the inpatient general pediatric and the population-based sample. 286 
For the comparison of prevalence data of symptoms of ARFID under consideration of 287 
patients’ weight status (self-reported underweight, objectively measured underweight) and 288 
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specific ARFID-related restrictive eating behaviors between both samples, Fisher’s Exact 289 
Tests were used.  290 
Second, the prevalence of symptoms of ARFID based on self-report plus medical 291 
record data was presented for the inpatient sample. To evaluate group differences between 292 
those with versus without symptoms of ARFID based on self-report and medical records in 293 
sex, weight status (underweight, normal weight, overweight), medical diagnoses, restrictive 294 
eating behaviors reported at least often (EDY-Q items ≥ 4), and clinically relevant scores in 295 
the ChEDE-Q8 and EDI-C (> 90th percentile), Fisher’s Exact Tests were conducted, while 296 
Mann-Whitney U tests were used for continuous variables (participant’s and parental age, 297 
child BMI-SDS, and KINDL subscale scores, and the HBSC-SCL total score) due to small 298 
group size and non-normally distributed data. To control for multiple testing on eating 299 
disorder psychopathology, an adjusted significance level of .05/4 = .0125 was used for 300 
analyses using the ChEDE-Q8 and EDI-C. 301 
All statistical analyses were performed with a two-tailed α < .05 using IBM SPSS 302 
Statistics version 24.0. Effect sizes for between-group differences were estimated using 303 
Hedges g for continuous variables and Cramer’s V for categorical variables, which can be 304 
interpreted as small (g ≥ 0.2, V[df = 1] ≥ 0.1, V[df = 2] ≥ 0.07), medium (g ≥ 0.5, V[df = 1] ≥ 305 
0.3, V[df = 2] ≥ 0.21), or large (g ≥ 0.8, V[df = 1] ≥ 0.5, V[df = 2] ≥ 0.35), respectively 306 
(Cohen, 1988). 307 
Results 308 
Symptoms of ARFID based on the EDY-Q 309 
Prevalence. In the inpatient sample, the prevalence of self-reported symptoms of 310 
ARFID was 0.9% (n = 1), see Table 1. Broad symptoms of ARFID were present in 7.2% (n = 311 
8; Table S1). After additionally considering objectively measured underweight, these rates 312 
amounted to 0.9 (n = 1) and 4.5% (n = 5). ARFID-related eating behaviors without self-313 
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reported underweight were more common (9.9 and 28.8%), as shown in the Supplement 314 
(Table S1).  315 
---Please include Table 1 here--- 316 
Inpatient Sample versus General Population Sample. Compared to boys and girls 317 
of the general population, symptoms of ARFID were not significantly more common in the 318 
inpatient sample, p > .05, based on any EDY-Q classification, except when considering 319 
objectively measured underweight (Supplement, Table S1). Significantly more children and 320 
adolescents from the inpatient sample met the broad EDY-Q criteria coupled with objectively 321 
measured underweight than those of the general population (4.5 versus 1.4%), p < .05, with 322 
small effect.  323 
Regarding the prevalence of single restrictive eating behaviors, significantly more 324 
children and adolescents of the inpatient sample reported overvaluation of weight and shape 325 
as well as selective eating compared to children and adolescents from the population, ps < .05, 326 
small effects. No significant group differences were found for any of the other items. 327 
Symptoms of ARFID based on Self-Report plus Medical Record Data 328 
Prevalence. Based on self-report and medical records, of those reporting any 329 
restrictive eating behaviors in the EDY-Q (n = 76, 69%), n = 16 (21%) met ARFID diagnostic 330 
criterion A1, 6 (8%) patients met criterion A2, while criteria A3 and A4 were met by n = 1 331 
(1%) each. Any A criterion was met by n = 21 (28%). Of those, all patients met ARFID 332 
diagnostic criterion B, n = 20 (95%) patients met diagnostic criterion C, while only n = 9 333 
(43%) patients met criterion D. In total, n = 12 patients had a medical diagnosis that 334 
exclusively accounted for ARFID-related eating behaviors and related physical symptoms. 335 
These diagnoses were initial manifestation of type 1 diabetes mellitus in 8 patients, complex 336 
GI syndromes in 3 patients, and a neurological disorder in 1 patient. In sum, 7.2% (n = 8) of 337 
the total sample showed symptoms of ARFID based on self-report and medical records (Table 338 
S2). Supplemental Table S4 provides an overview on case descriptions.  339 
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Sociodemographic Characteristics. Children and adolescents with versus without 340 
symptoms of ARFID based on self-report and medical records significantly differed in 341 
anthropometrics (Table 2). While 87.5% of children and adolescents with symptoms of 342 
ARFID had underweight (n = 7), 8.7% of those without symptoms of ARFID met the criteria 343 
for underweight (n = 9). Regarding BMI-SDS, children and adolescents with versus without 344 
symptoms of ARFID based on self-report and medical records had significantly lower values 345 
(p < .001), with large effects. No significant effects of children’s and parental 346 
sociodemographics (all ps > .05) on symptoms of ARFID based on self-report and medical 347 
records were seen.  348 
---Please include Table 2 here--- 349 
Restrictive eating behaviors. With respect to the EDY-Q item scores, children and 350 
adolescents with symptoms of ARFID based on self-report and medical records scored 351 
significantly higher on items for underweight, wish to gain weight, and selective eating than 352 
those without symptoms of ARFID (all ps < .05, medium to large effects), as shown in Table 353 
3. For all other items, no significant differences were found (p > .05, small to medium 354 
effects). 355 
Clinical Characteristics. Clinically, children and adolescents with versus without 356 
symptoms of ARFID based on self-report and medical records did not significantly differ in 357 
any of the measures on eating disorder psychopathology (p > .05, small effects). Both groups 358 
showed low eating disorder psychopathology (Table S3). Regarding quality of life, there was 359 
a non-significant, but medium-sized effect that children and adolescents with versus without 360 
symptoms of ARFID based on self-report and medical records reported lower mental quality 361 
of life. No significant group differences were found in the prevalence of self-reported physical 362 
quality of life or health complaints (p > .05, small effect). 363 
---Please include Table 3 here--- 364 
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Medical Diagnoses. Across the three main medical diagnoses (type 1 diabetes 365 
mellitus, GI disorders, neurological disorders), the prevalence of symptoms of ARFID based 366 
on self-report and medical records was not significantly different (p > .05). Symptoms of 367 
ARFID were likely met by 5.4% (n = 2) of children and adolescents with type 1 diabetes 368 
mellitus, 10.5% (n = 2) of children and adolescents with GI diseases, and 4.7% (n = 2) of 369 
those with neurological disorders. Of those with other diseases, 16.7% (n = 2) reported 370 
symptoms of ARFID. Specifically, there was one child each with a urological and one child 371 
with a respiratory disease that showed symptoms of ARFID based on self-report and medical 372 
records.  373 
Discussion 374 
To our knowledge, this is the first study investigating the prevalence and clinical 375 
correlates of symptoms of ARFID in a general inpatient sample of children and adolescents 376 
between 8 and 18 years, in addition to recent studies investigating symptoms of ARFID in 377 
pediatric samples of the same age range in gastroenterology (Eddy et al., 2015) and 378 
gynecology clinics (Goldberg et al., 2020). The study revealed a relatively high prevalence of 379 
symptoms of ARFID based on self-report plus medical records among inpatient children and 380 
adolescents, especially in those with underweight, without significant effects of age and sex. 381 
While there were no significant associations between symptoms of ARFID and medical 382 
diseases, about 10% of children and adolescents with GI diseases showed symptoms of 383 
ARFID after evaluating their self-report and medical records. The study replicated and 384 
extended previous findings (Becker et al., 2019; Kurz et al., 2015; Nakai et al., 2017) that 385 
children and adolescents with symptoms of ARFID reported more selective eating and 386 
underweight problems than those without these symptoms. 387 
Although the prevalence of ARFID-related restrictive eating behaviors was high in 388 
both the inpatient and population-based samples with rates of about 30%, only a minority of 389 
the samples reported underweight problems. The diagnostic coding of the EDY-Q including 390 
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self-reported underweight, absence of weight and shape concern, and specific restrictive 391 
eating behaviors, including sensory sensitivity, fear of choking, or lack of interest in eating 392 
(Kurz et al., 2015, 2016) as well as a broad inclusion of ARFID-related restrictive eating 393 
behaviors (Schmidt et al., 2018), revealed between 0.9 and 7.2% of inpatients showing these 394 
symptoms, which was not statistically different from the population-based sample. Notably, 395 
only a few patients actually had objectively measured underweight, which may be an indicator 396 
of the severity of eating disturbances, in addition to other co-occurring medical or 397 
psychosocial aspects (APA, 2013). As expected, compared to boys and girls of the general 398 
population, a wide range of self-reported ARFID-related restrictive eating behaviors coupled 399 
with objectively measured underweight were significantly more common in the inpatient 400 
sample. 401 
In contrast to expectations, no significant group differences between children and 402 
adolescents of the inpatient sample and the general population were found for the majority of 403 
restrictive eating behaviors as depicted by the items of the EDY-Q. Participants in the present 404 
sample only reported overvaluation of weight and shape as well as selective eating more often 405 
compared to children and adolescents from the population, in line with previous research on 406 
the association between disordered eating behavior and organic diseases (Machado, Dias, 407 
Lima, Campos, & Gonçalves, 2016; Olmsted, Colton, Daneman, Rydall, & Rodin, 2008). 408 
However, the higher overvaluation of weight and shape in the present than population-based 409 
sample could be due to the fact that this aspect is more common in girls and older children 410 
and adolescents (Hoffmann & Warschburger, 2017), given that the inpatient sample was 411 
somewhat older than the population-based sample. The non-significantly different rates of 412 
feelings of fatness, which also tap into the concept of weight and shape concern, may have a 413 
more pathological value than overvaluation of weight and shape and may thus be more 414 
common in eating disorder treatment-seeking settings. Notably, as the effects between the 415 
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inpatient and population-based samples were very small, the real differences in overvaluation 416 
of weight and shape and picky eating may not necessarily be clinically relevant.  417 
Based on self-reported ARFID-related restrictive eating behaviors in the absence of 418 
weight and shape concern and information derived from patients’ medical records, 7.2% of 419 
children and adolescents showed symptoms of ARFID. Most commonly, restrictive eating 420 
behaviors were coupled with ARFID diagnostic criterion A1 describing underweight, growth 421 
failure, or weight loss. Other diagnostic criteria relevant to ARFID, such as nutritional 422 
deficiency or enteral feeding, may indicate more severe or longstanding ARFID 423 
symptomatology, while weight problems become visible first. Although all children had a 424 
medical diagnosis, physical or mental comorbidity did not exclusively explain the restrictive 425 
eating behavior in most cases. Notably, Eddy et al. (2015) found a prevalence of only 1.5% of 426 
likely ARFID cases in a sample of treatment-seeking children in a pediatric gastroenterology 427 
healthcare network, a non-eating disorder sample similar to the present one. They additionally 428 
identified 2.4% of possible ARFID cases, where diagnosis could not be made due to missing 429 
information or interfering comorbidities. Considering only GI patients, prevalence of 430 
symptoms of ARFID based on self-report and medical records in the present sample was 431 
slightly higher with 10.5%, although group size was relatively small. Importantly, it is unclear 432 
in the present study if all children and adolescents actually met ARFID criteria as there was 433 
no clinical interview conducted. In clinical research of patients with eating disorders, 5-23% 434 
of presenting children and adolescents had a possible ARFID diagnosis (Fisher et al., 2014; 435 
Forman et al., 2014; Nicely et al., 2014; Norris et al., 2014; Ornstein et al., 2013). This higher 436 
prevalence is explainable by the fact that only patients who already had an eating disorder 437 
were included in these studies.  438 
Concerning medical diagnoses, there was no clear pattern for specific associations of 439 
GI and neurological diseases with symptoms of ARFID based on self-report and medical 440 
records, contrasting expectations. However, there was a trend for a relatively high prevalence 441 
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of symptoms of ARFID among children and adolescents with GI problems (10.5%), in line 442 
with findings linking a strong comorbidity of ARFID and organic diseases of the digestive 443 
system (Williams et al., 2015). As reported by Williams et al. (2015), a large proportion of 444 
children with symptoms of ARFID may present with medical conditions, particularly GI 445 
diseases, which may complicate the diagnostic decisions, as the medical disorders can be both 446 
artifact and reason of the diagnosis. In this context, initial manifestation of type 1 diabetes 447 
mellitus accounted for heavy weight loss in a substantial proportion of children reporting 448 
restrictive eating behaviors, making the diagnosis of ARFID inappropriate. Strikingly, the 449 
highest prevalence of symptoms of ARFID was found in children and adolescents with other 450 
diseases, including asthma and a urological disorder. Unfortunately, due to the small number 451 
of children and adolescents in these medical groups, prevalence rates of symptoms of ARFID 452 
must be considered with caution. 453 
Unlike hypotheses and other findings showing that patients with ARFID were 454 
predominately male (Eddy et al., 2015; Zickgraf, Murray, Kratz, & Franklin, 2019), 455 
symptoms of ARFID based on self-report and medical record were equally common in boys 456 
and girls in the present sample which corresponds to the DSM-5 (APA, 2013) and other 457 
population-based evidence (Hay et al., 2017; Kurz et al., 2015). In contrast to expectations, 458 
there were no significant age effects, which is however in line with a school-based study by 459 
Kurz et al. (2015). Regarding weight status, as expected, children and adolescents with 460 
underweight (44.4%) were more likely to show symptoms of ARFID based on self-report and 461 
medical records than children and adolescents with normal weight and overweight (1.4% and 462 
0.0%) which is consistent with a wide variety of findings (Bryant-Waugh et al., 2019; Kurz et 463 
al., 2015; Schmidt et al., 2018) and to be expected given ARFID’s DSM-5 diagnostic criteria, 464 
with underweight or weight loss being one of the central features. Restrictive eating disorders 465 
should therefore be considered in the case of underweight children and adolescents at every 466 
pediatric consultation.  467 
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Reflecting previous evidence on ARFID in children and adolescents from the 468 
population (Kurz et al., 2015, 2016; Nakai et al., 2017; Schmidt et al., 2018; Schmidt, Kirsten, 469 
Hiemisch, Kiess, & Hilbert, 2019), children and adolescents with versus without symptoms of 470 
ARFID based on self-report and medical records scored higher on EDY-Q items for 471 
underweight, wish to gain weight, and selective eating. As expected and in accordance with 472 
extant literature (APA, 2013; Becker et al., 2019; Bryant-Waugh et al., 2019; Kurz et al., 473 
2015) individuals with symptoms of ARFID based on self-report and medical records in this 474 
study showed very low global, although non-significantly different eating disorder 475 
psychopathology relative to children without ARFID, suggesting that the disturbed eating 476 
behavior is not driven by body image concern. The low level of eating disorder 477 
psychopathology in the population-based sample may explain why the smaller values for 478 
children and adolescents with symptoms of ARFID based on self-report and medical records 479 
were nevertheless not significantly different (floor effects). Importantly, as no healthy 480 
individuals from a community but inpatient children and adolescents from a pediatric hospital 481 
with various physical diseases were used as control group, the non-significant differences in 482 
quality of life and health complaints may be related to this aspect.  483 
The study’s strengths include the examination of a non-eating disorder clinical sample 484 
and the use of established self-report measures as well as the objective assessment of 485 
anthropometrics. DSM-5 criteria for ARFID were carefully inspected in the medical records 486 
of inpatient children and adolescents, thus, supplementing self-report data on ARFID. Among 487 
the limitations, the number of children and adolescents showing symptoms of ARFID was 488 
relatively small, resulting in difficulties to see significant group differences with the expected 489 
medium effect size. Due to the self-report nature of measures, only children and adolescents ≥ 490 
8 years were examined; however, as ARFID may develop at considerably younger ages 491 
(Sharp & Stubbs, 2019), it is highly valuable to consider ages of infancy and early childhood 492 
in future research. Since the present sample was older than the population-based sample, the 493 
 The final publication is available at https://doi.org/10.1002/erv.2799   
results of these comparative analyses may be biased by age effects. Because no standardized 494 
clinical interview was conducted to evaluate symptoms of ARFID more deeply, but only a 495 
medical record review, no definite conclusion about an actual ARFID diagnosis could be 496 
made. Additionally, the cross-sectional study design allows only a current snapshot of 497 
symptoms of ARFID and can neither map the development nor the consequences of the 498 
disorder.  499 
Conclusions 500 
In summary, our findings revealed that a relatively high proportion of inpatient 501 
children and adolescents in a general pediatric hospital showed symptoms of ARFID (7.2%) 502 
based on self-report and medical record data highlighting the importance of seriously 503 
considering eating disorders as a possible comorbidity in children and adolescents with 504 
physical complaints. Pediatricians for whom the new diagnosis of ARFID is still mainly 505 
unknown (Katzman, Stevens, & Norris, 2014), especially in countries predominately using the 506 
ICD-10 (World Health Organization, 1993), should be taught to have a focus on symptoms of 507 
ARFID to securely identify warning signs, such as underweight or abdominal pain. The 508 
motivation for ARFID-related restrictive eating behavior and underweight should be 509 
examined even in cases without body image concerns in everyday clinical practice.  510 
It is a question of future research to further investigate the relation between ARFID 511 
and organic diseases and a potential underlying motivation for restrictive eating behaviors in 512 
children and adolescents with a physical disorder. Longitudinal studies with larger sample 513 
sizes covering a broader age range may help identifying cause-and-effect connections between 514 
ARFID and its physical correlates, as it is currently unclear whether physical diseases are 515 
followed by ARFID or vice versa. Although self-report is a well-established way to assess 516 
children and adolescents at risk for eating disturbances, interview-based assessments (Bryant-517 
Waugh et al., 2019; Schmidt et al., 2019), parent-report, and detailed nutritional information 518 
would greatly enhance self-report. With these new insights, researchers may improve existing 519 
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assessment and treatment options in general pediatric hospitals as well as specialized eating 520 
disorder programs.  521 
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Table 1 
Prevalence (n, %) of symptoms of ARFID for the inpatient and general population samples based on the Eating Disorders in Youth-Questionnaire 
 
Inpatient sample  
(n = 111) 
General population sample 
(n = 799) 
p Fisher’s exact test  V 
Symptoms of ARFID  1 (0.9) 19 (2.4) .497 .03 
EDY-Q items reported at least „often“ (≥ 4)     
1. Food avoidance 7 (6.3) 47 (5.9) .829 .01 
2. Lack of interest in food 9 (8.1) 96 (12.0) .269 .04 
3. Emotional food avoidance 27 (24.3) 228 (28.5) .429 .03 
4. Underweight 19 (17.1) 93 (11.6) .120 .06 
5. Wish to gain weight 11 (9.9) 58 (7.3) .335 .03 
6. Weight concern (feelings of fatness) 21 (18.9) 148 (18.5) .869 .01 
7. Shape concern (overvaluation) 30 (27.0) 135 (16.9) .012 .09 
8. Selective eating behavior 55 (49.5) 293 (36.7) .009 .09 
9. Avoidance to try new foods 34 (30.6) 220 (27.5) .497 .03 
10. Fear of choking 3 (2.7) 36 (4.5) .614 .03 
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Inpatient sample  
(n = 111) 
General population sample 
(n = 799) 
p Fisher’s exact test  V 
11. Fear of swallowing 2 (1.8) 14 (1.8) .999 .00 
12. Sensory food avoidance 21 (18.9) 121 (15.1) .326 .04 
Note. ARFID Avoidant/Restrictive Food Intake Disorder. EDY-Q Eating Disorders in Youth-Questionnaire.  
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Table 2  
Sociodemographic and anthropometric characteristics for the inpatient sample with and without symptoms of ARFID based on self-report and 
medical records  
 Total sample  Symptoms of ARFID (medical records)  U p g or V 
 (n = 111) yes (n = 8) no (n = 103)    
 M (SD) M (SD) M (SD)    
Age, years  13.03 (2.94) 13.39 (2.97) 13.00 (2.95) 376.00 .681 0.13 
Sex, n (%)     .464b 0.08 
Girls 70 (63.1) 4 (50.0) 66 (64.1)    
Weight status, n (%)    χ²(2) = 37.39 <.001 0.58 
Underweight 16 (14.4) 7 (87.5) 9 (8.7)    
Normal weight 70 (63.1) 1 (12.5) 69 (67.0)    
Overweight 25 (22.5) 0 (0) 25 (24.3)    
BMI-SDS  0.15 (1.39) -1.65 (1.17) 0.30 (1.24) 85.50 < .001 1.58 
Mother's age, years 41.07 (6.41) 42.63 (6.57) 40.95 (6.42) 349.00 .496 0.26 
Father's age, years  45.22 (7.13) 46.38 (7.03) 45.13 (7.16) 329.50 .533 0.18 
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 Total sample  Symptoms of ARFID (medical records)  U p g or V 
 (n = 111) yes (n = 8) no (n = 103)    
 M (SD) M (SD) M (SD)    
Maternal education, n (%)a     .220b 0.14 
< 12 years 78 (71.6) 4 (50.0) 74 (71.8)    
≥12 years 31 (28.4) 4 (50.0) 27 (26.2)    
Paternal education, n (%)a     .192b 0.17 
< 12 years 68 (70.1) 3 (42.9) 65 (72.3)    
≥12 years 29 (29.9) 4 (57.1) 25 (27.2)    
Note. ARFID Avoidant/Restrictive Food Intake Disorder; BMI-SDS body mass index-standard deviation score.  
a Data do not add to 100% due to missing values. 
b Fisher’s exact test 
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Table 3 
Group differences in clinical variables between children and adolescents with and without symptoms of ARFID based on self-report and medical 
records 
 Symptoms of ARFID (medical records)    
 yes (n = 8)  no (n = 103) Test statistic p Fisher’s Exact Test  V 
 n (%) exceeding cutoffa  n (%) exceeding cutoffa    
EDY-Q items       
Food avoidanceb 0 (0)  7 (6.8)  .999 0.07 
Lack of interest in foodb 0 (0)  9 (8.7)  .999 0.08 
Emotional food avoidanceb 2 (25.0)  25 (24.3)  .999 0.00 
Underweight 5 (62.5)  14 (13.6)  .004 0.34 
Wish to gain weight 3 (37.5)  8 (7.8)  .031 0.26 
Weight concern (feelings of fatness)b 0 (0)  21 (20.4)  .306 0.49 
Shape concern (overvaluation)b 3 (37.5)  27 (26.2)  .358 0.21 
Selective eating behaviorb 8 (100.0)  47 (45.6)   .003 0.28 
Avoidance to try new foodsb 4 (50.0)  30 (29.1)  .246 0.12 
 The final publication is available at https://doi.org/10.1002/erv.2799   
 Symptoms of ARFID (medical records)    
 yes (n = 8)  no (n = 103) Test statistic p Fisher’s Exact Test  V 
 n (%) exceeding cutoffa  n (%) exceeding cutoffa    
Fear of chokingb 1 (12.5)  2 (1.9)  .203 0.17 
Fear of swallowingb 0 (0)  2 (1.9)  .999 0.04 
Sensory food avoidanceb 3 (37.5)  18 (17.5)  .173 0.13 
ChEDE-Q8 global score 0 (0)  11 (10.7)  .999 0.10 
EDI-C drive for thinness 1 (12.5)  15 (14.6)  .999 0.02 
EDI-C bulimia 1 (12.5)  20 (19.4)  .999 0.05 
EDI-C body dissatisfaction 0 (0)  9 (8.7)  .999 0.08 
 M (SD)  M (SD) U p g 
KINDL physical well-being  7.63 (5.37)  9.19 (4.04) 342.50 .426 0.38 
KINDL emotional well-being  9.63 (3.25)  11.17 (3.01) 290.50 .163 0.51 
HBSC-SCL, M (SD) 23.63 (3.85)  23.53 (5.66) 381.00 .755 0.02 
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Note. ARFID Avoidant/Restrictive Food Intake Disorder; ChEDE-Q8 Eating Disorder Examination-Questionnaire for Children 8; EDI-C Eating 
Disorder Inventory for Children; EDY-Q Eating Disorders in Youth-Questionnaire; HBSC-SCL Health Behavior in School-aged Children Symptom 
Checklist; KINDL KINDL-R questionnaire; M mean value; SD standard deviation.  
a EDY-Q items ≥ 4, EDI-C and ChEDE-Q8 ≥ 90th age- and sex-specific percentiles 
bUsed as indicator variables for evaluating presence of symptoms of ARFID in addition to medical records 
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Supplement to “Characteristics of avoidant/restrictive food intake disorder in a general paediatric inpatient sample” (Schöffel et al.) 
 
 
Table S1. Comparative overview of EDY-Q categories previously reported in the literature considering objectively measured underweight 
and related problems for the inpatient (N = 111) and population-based samples (N = 799). 
 








  n (%) n (%)   
Symptoms of ARFIDa without 
underweight problems 
(items 2 or 10 or 12 ≥ 4) AND (item 6 < 3 and item 7 
< 3) 
11 (9.9) 110 (13.8) .299 .04 
Symptoms of ARFIDa with 
objectively measured underweight 
(items 2 or 10 or 12 ≥ 4) AND (item 4 ≥ 4) AND 
(BMI-SDS < -1.28) AND (item 6 < 3 and item 7 < 3) 
1 (0.9) 19 (2.4) .497 .03 
Broad symptoms of ARFIDb 
(items 1 or 2 or 3 or 8 or 9 or 10 or 11 or 12 ≥ 4) 
AND (item 4 ≥ 4) AND (item 6 < 3 and item 7 < 3) 
8 (7.2) 44 (5.5) .510 .02 
Broad symptoms of ARFIDb 
without underweight problems 
(items 1 or 2 or 3 or 8 or 9 or 10 or 11 or 12 ≥ 4) 
AND (item 6 < 3 and item 7 < 3) 
32 (28.8) 285 (35.7) .168 .05 
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Broad symptoms of ARFIDb with 
objectively measured underweight 
(items 1 or 2 or 3 or 8 or 9 or 10 or 11 or 12 ≥ 4) 
AND (item 4 ≥ 4) AND (BMI-SDS < -1.28) AND 
(item 6 < 3 and item 7 < 3) 
5 (4.5) 11 (1.4) .036 .08 
Note. BMI-SDS Body Mass Index-Standard Deviation Score; EDY-Q Eating Disorders in Youth-Questionnaire. 
 
aKurz, S., van Dyck, Z., Dremmel, D., Munsch, S., & Hilbert, A. (2015). Early-onset restrictive eating disturbances in primary school boys and 
girls. European Child & Adolescent Psychiatry, 24, 779–785.  
bSchmidt, R., Vogel, M., Hiemisch, A., Kiess, W., & Hilbert, A. (2018). Pathological and non-pathological variants of restrictive eating behaviors in 
middle childhood: A latent class analysis. Appetite, 127, 257–265.  
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Table S2. Guideline for self-report and medical record ratings to decide whether diagnostic criteria for ARFID would be met and related 
frequencies.  
  
Diagnostic criterion Operationalization Criterion met  
 




Criterion A: eating or feeding disturbance 
manifested by persistent failure to meet 
appropriate nutritional and/or energy needs 
EDY-Q: ≥ 4 for any item on restrictive 
eating behaviors (1, 2, 3, 8, 9, 10, 11, 12) 
76 (68) 35 (32%) 
 
 







A1: significant weight loss/faltering 
growth 
Medical records: < 10th BMI percentile, 
significant weight loss (> 5% in 3 
months), expected weight gain failed 
16 (21) 60 (79)  
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A2: significant nutritional deficiency 
Medical records: indication for vitamin 
or mineral deficiency by blood samples, 
physical symptoms of malnutrition due to 
reduced food intake (e.g., dizziness) 
6 (8) 70 (92)  
A3: dependence on enteral feeding or oral 
nutritional supplements 
Medical records: any presence of oral 
nutritional supplements (prescribed 
vitamins, high-calorie food) or tube 
feeding unrelated to other physical illness 
1 (1) 75 (99)  
A4: marked interference with psychosocial 
functioning 
Medical records: reports of psychological 
symptoms due to restricted food intake 
(e.g., sadness, aggressiveness, school 
problems, teasing) 
1 (1) 75 (99)  
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Criterion B: not better explained by lack of 
available food or culture 
Medical records: no indication of 
financial reasons, neglect, or culturally 
accepted eating behaviors  
21 (100) 0   
Criterion C: criteria for anorexia nervosa or 
bulimia nervosa not met and no evidence 
of body image disturbance 
Medical records: no diagnosis of 
anorexia nervosa or bulimia nervosa 
EDY-Q items on weight and shape 
concern: < 3 
20 (95) 1 (5)   
Criterion D: not attributable to a concurrent 
medical condition or not better explained 
by another mental disorder, or additional 
clinical attention 
Medical records: no comorbid diagnoses 
with explicit consequences on eating 
behaviors or weight loss or, in presence 
of a comorbidity, ARFID-related eating 
behavior is deemed to persist when 
comorbidity remits or gives additional 
information for treatment  
9 (43) 12 (57)   
Patients meeting ARFID symptoms based 
on self-report and medical records 
 8    
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Table S3. Continuous (M, SD) data on eating disorder psychopathology for patients with and without symptoms of ARFID based on self-
report and medical records and their reference to community and clinical norms.  
 
 
ARFID symptoms (medical records)  
 
 No ARFID symptoms (medical records) 
 
 (n = 8)  Mean reference percentile  (n = 103)  Mean reference percentile 
 M (SD)  Community norms Clinical norms  M (SD)  Community norms Clinical norms 
ChEDE-Q8 global score 0.42 (0.42)  50 -  0.91 (1.48)  64 - 
EDI-C drive for thinness 4.25 (3.69)  < 75 < 10  6.97 (8.77)  < 75 < 25 
EDI-C bulimia 6.38 (6.35)  < 90 < 50  5.40 (6.63)  < 75 < 50 
EDI-C body dissatisfaction 8.50 (5.53)  < 50 < 10  13.07 (11.95)  < 75  < 25 
Note. Continuous mean scores on eating disorder psychopathology were referenced to mean norm rankings based on community-based samples 
and, for the EDI-C, for clinical samples with eating disorders. ARFID Avoidant/restrictive food intake disorder, ChEDE-Q8 Eating Disorder 
Examination-Questionnaire for Children 8, EDI-C Eating Disorder Inventory for Children. 
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Emotional food avoidance, 
picky eating, sensory food 
avoidance 
6.00 3.00 17.00 0.50 




Picky eating 1.00 8.00 8.00 0.25 




Picky eating, food 
neophobia, sensory food 
avoidance 
9.00 3.00 8.00 1.38 
4 m 11 164.00 38.75 -1.79 





Picky eating 3.00 5.00 10.00 0.38 
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(vitamin A, selen) 
Picky eating, food 
neophobia 
10.00 21.00 5.00 0.25 




Picky eating, food 
neophobia, sensory food 
avoidance 
0.00 1.00 5.00 0.00 
7 f 13 143.00 25.00 -3.97 





Picky eating 2.00 7.00 15.00 0.50 




Emotional food avoidance, 
picky eating, food 
neophobia, fear of choking 
3.00 3.00 0.00 0.13 
ARFID Avoidant/restrictive food intake disorder, BMI-SDS Body Mass Index Standard Deviation Score; ChEDE-Q8 Eating Disorder Examination-
Questionnaire for Children 8, EDI-C Eating Disorder Inventory for Children, DT Drive for Thinness, B Bulimia, BD Body Dissatisfaction; EDY-Q 
Eating Disorders in Youth-Questionnaire 
 
